Cancer patients
AI-Powered Prostate Cancer Diagnosis Trial Set to Revolutionize Treatment Decisions
Researchers at the University of Oxford have launched a trial in Bristol to explore the potential of artificial intelligence (AI) in making better treatment decisions for prostate cancer patients. The Vanguard Path study aims to address the challenge faced by doctors in determining the aggressiveness of the disease in individual